SCHEMBL22708623

SCHEMBL22708623

c1ccc(-c2cc3oc4c(ccc5[nH]c6cc(N(c7ccccc7)c7ccccc7)ccc6c54)c3c3ccccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 6/20 0.34
▸ CCND1 P24385 6/20 0.34
▸ HPGD P15428 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CHEK1 O14757 1/20 0.32
▸ WEE1 P30291 1/20 0.32
▸ GABRP O00591 1/20 0.31
▸ GABRD O14764 1/20 0.31
▸ GABRA1 P14867 1/20 0.31
▸ GABRB1 P18505 1/20 0.31
▸ GABRG2 P18507 1/20 0.31
▸ GABRB3 P28472 1/20 0.31
▸ GABRA5 P31644 1/20 0.31
▸ GABRA3 P34903 1/20 0.31
▸ GABRA2 P47869 1/20 0.31
▸ GABRB2 P47870 1/20 0.31
▸ GABRA4 P48169 1/20 0.31
▸ GABRE P78334 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22708873 0.87 CDK4 (0.34) CDK4CCND1HPGDHTTSMN1; SMN2
SCHEMBL22708418 0.85 HPGD (0.45) CDK4CCND1HPGDHTTSMN1; SMN2
SCHEMBL22708395 0.84 CDK4 (0.48) CDK4CCND1HPGDHTTSMN1; SMN2
SCHEMBL22708507 0.82 GABRP (0.37) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL22708610 0.80 GABRP (0.38) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL26587874 0.79 ALOX5 (0.39) SMN1; SMN2KDM4EALDH1A1LMNA
SCHEMBL26587933 0.79 ALOX5 (0.41) SMN1; SMN2KDM4EALDH1A1LMNA
SCHEMBL22708746 0.78 CDK4 (0.40) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL26587981 0.77 AKR1B1 (0.35) HPGDHTTSMN1; SMN2MAPK1WEE1
SCHEMBL22708880 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same LT MATERIALS CO., LTD. (KR) 2023-02-21 — — US disclosed
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LT MATERIALS CO., LTD. (KR) 2020-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 CDK4 185/4885CCND1 114/4885HPGD 766/4885
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 CDK4 185/4885CCND1 114/4885HPGD 766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback